Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 24, Issue 4

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 24, Issue 4 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 24, Issue 4 (2015)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Volume 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Investigational Drugs for Affective Disorders

Foreword

David Grech

Page: 443

Published online: 13 Mar 2015

CitationforForeword | Full Text | PDF (80.8 KB)

52 Views
0 CrossRef citations
0Altmetric

Editorial

Criticisms of drugs in early development for the treatment of depression: what can be improved?

Sheng-Min Wang, Changsu Han & Chi-Un Pae

Pages: 445-453

Published online: 20 Dec 2014

AbstractforCriticisms of drugs in early development for the treatment of depression: what can be improved? | Full Text | References | PDF (218.9 KB)

2128 Views
10 CrossRef citations
0Altmetric

Free Access

Editorial

Why have early investigational therapies of obsessive–compulsive disorder failed to materialise?

Donatella Marazziti (Adjunct Professor of Psychiatry) MD & Liliana Dell’Osso (Full Professor of Psychiatry) MD

Pages: 455-458

Published online: 20 Jan 2015

AbstractforWhy have early investigational therapies of obsessive–compulsive disorder failed to materialise? | Full Text | References | PDF (99.9 KB)

1001 Views
8 CrossRef citations
0Altmetric

Free Access

Review

Novel investigational drugs targeting IL-6 signaling for the treatment of depression

Trehani M Fonseka, Roger S McIntyre, Joanna K Soczynska & Sidney H Kennedy

Pages: 459-475

Published online: 14 Jan 2015

AbstractforNovel investigational drugs targeting IL-6 signaling for the treatment of depression | Full Text | References | PDF (592.4 KB)

745 Views
37 CrossRef citations
0Altmetric

Drugs under early investigation for the treatment of bipolar disorder

George Konstantakopoulos, Stefanos Dimitrakopoulos & Panayiota G Michalopoulou

Pages: 477-490

Published online: 23 Feb 2015

AbstractforDrugs under early investigation for the treatment of bipolar disorder | Full Text | References | PDF (300.7 KB)

459 Views
7 CrossRef citations
0Altmetric

Novel investigational therapeutics for panic disorder

Giampaolo Perna MD PhD, Koen Schruers MD PhD, Alessandra Alciati MD & Daniela Caldirola MD PhD

Pages: 491-505

Published online: 24 Dec 2014

AbstractforNovel investigational therapeutics for panic disorder | Full Text | References | PDF (322.7 KB)

519 Views
25 CrossRef citations
0Altmetric

Investigational drugs for anxiety in patients with schizophrenia

Ricardo P Garay, Ludovic Samalin, Ahcène Hameg & Pierre-Michel Llorca

Pages: 507-517

Published online: 25 Nov 2014

AbstractforInvestigational drugs for anxiety in patients with schizophrenia | Full Text | References | PDF (345.1 KB)

683 Views
18 CrossRef citations
0Altmetric

Novel metabotropic glutamate receptor 4 and glutamate receptor 8 therapeutics for the treatment of anxiety

Jacob Raber PhD & Robert M Duvoisin

Pages: 519-528

Published online: 17 Dec 2014

AbstractforNovel metabotropic glutamate receptor 4 and glutamate receptor 8 therapeutics for the treatment of anxiety | Full Text | References | PDF (439.5 KB)

459 Views
11 CrossRef citations
0Altmetric

Thinking small: towards microRNA-based therapeutics for anxiety disorders

Karen A Scott, Alan E Hoban, Gerard Clarke, Gerard M Moloney, Timothy G Dinan & John F Cryan

Pages: 529-542

Published online: 08 Jan 2015

AbstractforThinking small: towards microRNA-based therapeutics for anxiety disorders | Full Text | References | PDF (505.5 KB)

551 Views
30 CrossRef citations
0Altmetric

The failure of anxiolytic therapies in early clinical trials: what needs to be done

Adam Michael Stewart, Michael Nguyen, Manoj K Poudel, Jason E Warnick, David J Echevarria, Elliott A Beaton, Cai Song & Allan V Kalueff

Pages: 543-556

Published online: 01 Mar 2015

AbstractforThe failure of anxiolytic therapies in early clinical trials: what needs to be done | Full Text | References | PDF (611.5 KB)

265 Views
14 CrossRef citations
0Altmetric

Discontinued Drug Perspective

Discontinued anxiolytic drugs (2009 – 2014)

Roberto Mandrioli & Laura Mercolini

Pages: 557-573

Published online: 05 Jan 2015

AbstractforDiscontinued anxiolytic drugs (2009 – 2014) | Full Text | References | PDF (524.1 KB)

342 Views
6 CrossRef citations
0Altmetric

Drug Evaluation

Potential use of lurasidone for the treatment of bipolar psychosis

Mauro Giovanni Carta, Maria Francesca Moro, Antonio E Nardi & Joseph R Calabrese (Bipolar Disorders Research Chair, Professor of Psychiatry Dir)

Pages: 575-584

Published online: 30 Jan 2015

AbstractforPotential use of lurasidone for the treatment of bipolar psychosis | Full Text | References | PDF (284.1 KB)

322 Views
3 CrossRef citations
0Altmetric

Pregabalin for the treatment of social anxiety disorder

Paweł Kawalec, Agnieszka Cierniak, Andrzej Pilc & Gabriel Nowak

Pages: 585-594

Published online: 31 Oct 2014

AbstractforPregabalin for the treatment of social anxiety disorder | Full Text | References | PDF (283.1 KB)

753 Views
17 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.24, Iss.4, 2015)

Investigational Drugs for Affective Disorders

Investigational Drugs for Affective Disorders

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?

Information for

Authors
R&D professionals
Editors
Librarians
Societies

Open access

Overview
Open journals
Open Select
Dove Medical Press
F1000Research

Opportunities

Reprints and e-prints
Advertising solutions
Accelerated publication
Corporate access solutions

Help and information

Help and contact
Newsroom
All journals
Books

Keep up to date

Sign me up

Taylor and Francis Group Facebook page

Taylor and Francis Group X Twitter page

Taylor and Francis Group Linkedin page

Taylor and Francis Group Youtube page

Taylor and Francis Group Weibo page

Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG

Citation search

Your download is now in progress and you may close this window

Login or register to access this feature

Expert Opinion on Investigational Drugs, Volume 24, Issue 4 (2015)

Expert Opinion on Investigational Drugs, Volume 24, Issue 4 (2015)

Investigational Drugs for Affective Disorders

Foreword

Editorial

Review

Discontinued Drug Perspective

Drug Evaluation

Further Readings

Explore articles

Download citations

Choose format

Access Rights

Information for

Open access

Opportunities

Help and information

Keep up to date